title: Patient derived cell culture and isolation of CD133⁺ putative cancer stem cells from melanoma.
abstract: Despite improved treatments options for melanoma available today, patients with advanced malignant melanoma still have a poor prognosis for progression-free and overall survival. Therefore, translational research needs to provide further molecular evidence to improve targeted therapies for malignant melanomas. In the past, oncogenic mechanisms related to melanoma were extensively studied in established cell lines. On the way to more personalized treatment regimens based on individual genetic profiles, we propose to use patient-derived cell lines instead of generic cell lines. Together with high quality clinical data, especially on patient follow-up, these cells will be instrumental to better understand the molecular mechanisms behind melanoma progression. Here, we report the establishment of primary melanoma cultures from dissected fresh tumor tissue. This procedure includes mincing and dissociation of the tissue into single cells, removal of contaminations with erythrocytes and fibroblasts as well as primary culture and reliable verification of the cells' melanoma origin. Recent reports revealed that melanomas, like the majority of tumors, harbor a small subpopulation of cancer stem cells (CSCs), which seem to exclusively fuel tumor initiation and progression towards the metastatic state. One of the key markers for CSC identification and isolation in melanoma is CD133. To isolate CD133(+) CSCs from primary melanoma cultures, we have modified and optimized the Magnetic-Activated Cell Sorting (MACS) procedure from Miltenyi resulting in high sorting purity and viability of CD133(+) CSCs and CD133(-) bulk, which can be cultivated and functionally analyzed thereafter.
authors.affiliation: Institute of Pathology, Laboratory of Molecular Tumor Pathology, Charité - Universitätsmedizin Berlin. yvonne.welte@charite.de
authors.forename: Yvonne
authors.initials: Y
authors.lastname: Welte
authors.forename: Cathrin
authors.initials: C
authors.lastname: Davies
authors.forename: Reinhold
authors.initials: R
authors.lastname: Schäfer
authors.forename: Christian R A
authors.initials: CR
authors.lastname: Regenbrecht
mesh_terms: D000071916:AC133 Antigen; D015703:Antigens, CD / Q000276:immunology*; D006023:Glycoproteins / Q000276:immunology*; D006801:Humans; D018189:Immunomagnetic Separation / Q000379:methods*; D008545:Melanoma / Q000276:immunology* / Q000473:pathology*; D014411:Neoplastic Stem Cells / Q000276:immunology* / Q000473:pathology*; D010455:Peptides / Q000276:immunology*
chemical_list: D000071916:AC133 Antigen; D015703:Antigens, CD; D006023:Glycoproteins; C000606023:PROM1 protein, human; D010455:Peptides